Kenneth Jacobs
Mersana Therapeutics (United States)
ORCID: 0000-0002-7544-9772Also affiliated with KU Leuven
MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Top 100%percentile
Indexed papers
0in pilot corpus
Papers
Driven by 2 papers. Top paper: “Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia”.
N/A
322 citations
Ibrahim Aldoss, Matthew C. Foster, Peter H. Sayre, Matthew J. Wieduwilt, Anjali S. Advani +43 more
N/A
19 citations
Ibrahim Aldoss, Shannon L. Maude, Deepa Bhojwani, Alan S. Wayne, Ashish Bajel +28 more